Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,317 | -51,115 | -53,337 | N/A | N/A |
| Depreciation Amortization | 2,907 | 2,021 | 666 | N/A | N/A |
| Income taxes - deferred | -1,361 | 117 | N/A | N/A | N/A |
| Accounts receivable | 3,884 | -6,134 | -8 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,384 | 820 | 121 | N/A | N/A |
| Other Working Capital | 4,209 | 592 | 342 | N/A | N/A |
| Other Operating Activity | 3,302 | 6,692 | 824 | 0 | 0 |
| Operating Cash Flow | $-48,760 | $-47,007 | $-51,392 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,527 | -989 | -1,021 | N/A | N/A |
| Net Acquisitions | N/A | -47,811 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,527 | $-48,800 | $-1,021 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 51,331 | 99,400 | 52,413 | 0 | 0 |
| Financing Cash Flow | $51,331 | $99,400 | $52,413 | $N/A | $N/A |
| Beginning Cash Position | 3,593 | N/A | N/A | N/A | N/A |
| End Cash Position | 4,637 | 3,593 | N/A | N/A | N/A |
| Net Cash Flow | $1,044 | $3,593 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,760 | -47,007 | -51,392 | N/A | N/A |
| Capital Expenditure | -1,527 | -989 | -1,021 | N/A | N/A |
| Free Cash Flow | -50,287 | -47,996 | -52,413 | 0 | 0 |